Caricamento...
Predictive value of C-reactive protein in patients treated with sunitinib for metastatic clear cell renal cell carcinoma
BACKGROUND: Sunitinib has become mainstay first line treatment for patients with metastatic renal clear cell carcinoma (mRCC). Still, useful predictive markers of response are lacking and urgently needed for clinical decision making. METHODS: In the present study we investigated the predictive value...
Salvato in:
| Pubblicato in: | BMC Urol |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5580299/ https://ncbi.nlm.nih.gov/pubmed/28859644 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-017-0267-6 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|